SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0001104659-24-057314 from DarioHealth Corp. (DRIO)

DarioHealth Corp.
Date: May 6, 2024 · CIK: 0001533998 · Accession: 0001104659-24-057314

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-278865

Date
May 6, 2024
Author
Zvi Ben David
Form
CORRESP
Company
DarioHealth Corp.

Letter

DarioHealth Corp.

322 W. 57th St. #33B

New York, New York

May 6, 2024

VIA EDGAR

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, DC 20549

RE: DarioHealth Corp. (CIK: 0001533998)

Registration Statement No. 333-278865 on Form S-3 (the “Registration Statement”), as amended

Ladies and Gentlemen:

DarioHealth Corp. (the “Registrant”) hereby requests acceleration of the effectiveness of the above-referenced Registration Statement pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Securities Act”), so that it may become effective on May 8, 2024, at 4:30 p.m., Eastern Time, or as soon thereafter as is practicable.

The Registrant understands that the Securities and Exchange Commission will consider this request for acceleration of the effective date of the Registration Statement as a confirmation of the fact that the Registrant is aware of its responsibilities under the Securities Act and the Securities Exchange Act of 1934, as amended, as they relate to the proposed public offering of the securities specified in the Registration Statement.

Very truly yours,
DARIOHEALTH CORP.

Show Raw Text
CORRESP
1
filename1.htm

DarioHealth Corp.

322 W. 57th St. #33B

New York, New York

May 6, 2024

VIA EDGAR

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, DC 20549

    RE:
    DarioHealth Corp. (CIK: 0001533998)

    Registration Statement No. 333-278865 on Form S-3 (the “Registration Statement”), as amended

Ladies and Gentlemen:

DarioHealth Corp. (the “Registrant”)
hereby requests acceleration of the effectiveness of the above-referenced Registration Statement pursuant to Rule 461 under the Securities
Act of 1933, as amended (the “Securities Act”), so that it may become effective on May 8, 2024, at 4:30 p.m., Eastern
Time, or as soon thereafter as is practicable.

The Registrant understands
that the Securities and Exchange Commission will consider this request for acceleration of the effective date of the Registration Statement
as a confirmation of the fact that the Registrant is aware of its responsibilities under the Securities Act and the Securities Exchange
Act of 1934, as amended, as they relate to the proposed public offering of the securities specified in the Registration Statement.

    Very truly yours,

    DARIOHEALTH CORP.

    By:
    /s/ Zvi Ben-David

    Zvi Ben David, Chief Financial Officer